Ikarian Capital’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,714
Closed -$1.34M 168
2022
Q2
$1.34M Sell
23,714
-22
-0.1% -$1.2K 0.24% 70
2022
Q1
$1.4M Buy
23,736
+1,141
+5% +$58.1K 0.18% 87
2021
Q4
$1.56M Hold
22,595
0.23% 79
2021
Q3
$1.62M Sell
22,595
-285
-1% -$22.2K 0.11% 136
2021
Q2
$1.92M Hold
22,880
0.15% 134
2021
Q1
$1.6M Buy
+22,880
New +$1.79M 0.05% 216

Other funds holding NTBL

Ikarian Capital's NTBL Position: Q3 2022 in Review

Ikarian Capital sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q3 2022, closing a stake of 23,714 shares — an estimated $1.34M sold.

Ikarian Capital first reported a position in NTBL in Q1 2021 and held it in 6 quarters. The position peaked at $1.92M in Q2 2021. 26 funds tracked by Wall St. Rank hold NTBL as of Q3 2022.

  • Ikarian Capital reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 23,714 Notable Labs, Ltd. Ordinary Shares shares in Q3 2022, an estimated $1.34M.
  • Ikarian Capital first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2021 and held it in 6 quarters.
  • Ikarian Capital's Notable Labs, Ltd. Ordinary Shares position peaked at $1.92M in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.